|Articles|September 19, 2019
Schizophrenia Q&A: Depot Medications in Schizophrenia Therapy
Author(s)Peter F. Buckley, MD
Key Takeaways
- Clinical selection for depot antipsychotics is framed as a multifactorial decision tailored to individual patients with schizophrenia.
- A second focus is on actionable interventions that can increase acceptance and utilization of depot medications in clinical practice.
In this video segment, Dr. Peter Buckley addresses 2 questions: • What factors do you consider when you offer depot medications to a patient with schizophrenia? • What can be done to encourage the use of depot medications?
Advertisement
In this video clip, Dr Peter Buckley addresses 2 questions:
• What factors do you consider when you offer depot medications to a patient with schizophrenia?
• What can be done to encourage the use of depot medications?
This video was originally posted on June 19, 2012 and has since been updated with permission from Dr Buckley. -Ed
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Podcast: Early Intervention & Psychopharmacology in Bipolar Disorder With Robert M. Post, MD
2
New Positive Phase 2 Topline Data on Elunetirom for the Treatment of Bipolar Depression
3
Suicide Risk Assessment in Patients Denying Suicidal Intent
4
Adjunctive Atypical Antipsychotics in Major Depressive Disorder: Comparing Efficacy and Tolerability
5